North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- James Gossage
- Study ID
- NCT01408030
- Phase
- PHASE2
- Status
- Completed
Conditions
- Epistaxis
- Telangiectasia, Hereditary Hemorrhagic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sterile saline — DRUG0.9%, 0.1 ml spray in each nostril bid
- Bevacizumab — DRUG1% solution in saline, 0.1 ml spray in each nostril bid
- Estriol — DRUG0.1% suspension in methylcellulose, 0.1 ml spray in each nostril bid
- Tranexamic Acid — DRUG10% solution in saline, 0.1 ml spray in each nostril bid
Study Details
The purpose of the NOSE Study is to carefully examine the efficacy and safety of 3 nasal sprays (bevacizumab, estriol, and tranexamic acid), compared to placebo, for the treatment of HHT related nosebleeds.
Key Dates
- First listed
- Aug 2, 2011
- Start date
- Aug 31, 2011
- Status verified
- Oct 2018
- Primary completion
- Sep 30, 2014
- Completion
- Sep 30, 2014
Study Design
- Enrollment
- 123 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Placebo spraysterile saline
- Active Comparator: Bevacizumab spraybevacizumab 1%
- Active Comparator: Estriol sprayEstriol 0.1%
- Active Comparator: Tranexamic acid spraytranexamic acid 10%
Primary Outcome Measure
Frequency of Epistaxis [ Time Frame: Weeks 5-12 of active treatment phase ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Los Angeles | Los Angeles | California | 90095 | - |
| Georgia Regents University | Augusta | Georgia | 30912 | - |
| Johns Hopkins University | Baltimore | Maryland | 21205 | - |
| Washington University School of Medicine | St Louis | Missouri | 63110 | - |
| Oregon Health Sciences University | Portland | Oregon | 97239 | - |
| University of Utah | Salt Lake City | Utah | 84132 | - |
Find similar trials in Los Angeles, CA
Related Studies
- Comprehensive HHT Outcomes Registry of the United States (CHORUS)Recruiting · Cure HHT · Birmingham, Alabama
- Topical TOR-582 Treatment of Epistaxis in HHTPHASE1 · Recruiting · Columbia University · New York, New York